Chapters
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 | Alfuzosin M/R tablets | ||
| Alfuzosin tablets | ||
 | Alprostadil cream (Vitaros) | Specialist initiation. For patients who would otherwise use alprostradil injection. | |
| Alprostadil injection | ||
| Aviptadil 25mcg / Phentolamine 2mg intracavernosal injection (Invicorp®) | Approved on formulary December 2017. Specialist initiation. Third line after oral PDE-5 inhibitors failed and patient not responding to or intolerant of alprostadil. To be reviewed within 12 months to assess alprostadil supply issues and patent expiry | |
 | BCG (OncoTice®) bladder installation | ||
| Bethanechol chloride | ||
| Bladder cocktail urological solution | ||
| Botulinum toxin type A | ||
| Catheter patency solution - sodium chloride | ||
| Chlorhexidine bladder wash | ||
| Chondroitin sulfate urological solution (Uracyst®) | ||
| Dimethyl sulphoxide bladder installation 50% | ||
| Doxazosin | ||
| Duloxetine capsule | ||
| Glycine | ||
| Hyuralonic acid (Hyacyst®) | ||
| Mirabegron | ||
| Oxybutynin M/R tablets | ||
| Oxybutynin patch (Kentera) | If first line is not tolerated, following specialist advice | |
| Oxybutynin tablets | ||
| Potassium citrate mixture BP | ||
| Sildenafil tablets | Sildenafil tablets generic | |
| Sodium bicarbonate powder | ||
| Sodium citrate | ||
| Solifenacin tablets | ||
| Tadalafil 10mg | High relative cost. In line with SLS criteria. Four tab per month - on demand. Non-formulary for LUTS in BPS. | |
| Tolterodine M/R capsules | High relative cost. Second line. | |
| Tolterodine tablets | ||
| Trospium MR capsules | Over 65 year old | |
| Trospium tablets | Over 65 year old | |
| Vacuum pumps | Green - if in line with SLS criteria | |
| Vacuum pumps | Red - if not in line with the SLS criteria |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
